Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorHelios Kliniken Schwerin
About this trial
The aim of this prospective randomized study is to evaluate whether telemedical assistance via SmartGlasses is equivalent to physical presence in teaching Endoscopic Retrograde Cholangiopancreaticography (ERCP) in terms of examination success and safety. Endoscopic papilla cannulation is a key skill for successful ERCP and therefore a measurable primary endpoint of the study. This can be measured as the time (in seconds/minutes) between stable visualization of the papilla and successful endoscopic cannulation of the target structure (bile duct or pancreatic duct).
Eligibility criteria
Qualifiers
Adult patients aged ≥ 18 years without previous papillotomy
Disqualifiers
Cannulation of the minor papilla necessary
Significant comorbidity
Haemodynamic instability
Pregnant women
Trial design
Treatments tested in this trial
- Training in presence of the instructor
- Telemedically training by an instructor
Treatment groups
170 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov